{"transactions":[{"id":704231,"issuer":{"id":2904,"kind":"organization","name":"MCKESSON CORP","symbol":"MCK"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2026-07-23T20:43:32.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted pursuant to an annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"RSUs granted pursuant to an annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board."}],"balance_after":277,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":277},"source":{"system":"sec-edgar","filing":"0000927653-26-000200","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927653/000092765326000200/form4.xml","form_type":"4"}},{"id":774529,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T22:21:00.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":14058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":14058,"derivative":{"exercise_price":25.8,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":14058},"source":{"system":"sec-edgar","filing":"0001193125-26-229222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000119312526229222/ownership.xml","form_type":"4"}},{"id":774528,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T22:21:00.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":38566,"source":{"system":"sec-edgar","filing":"0001193125-26-229222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000119312526229222/ownership.xml","form_type":"4"}},{"id":1078648,"issuer":{"id":2904,"kind":"organization","name":"MCKESSON CORP","symbol":"MCK"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2025-07-31T22:31:31.000Z","date":"2025-07-30","kind":"grant","planned":false,"acquired":true,"shares":301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted pursuant to an annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"RSUs granted pursuant to an annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board."}],"balance_after":301,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":301},"source":{"system":"sec-edgar","filing":"0000927653-25-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000088/form4.xml","form_type":"4"}},{"id":1142147,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-19T22:31:42.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":10787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":10787,"derivative":{"exercise_price":34.84,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":10787},"source":{"system":"sec-edgar","filing":"0000950170-25-074662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017025074662/ownership.xml","form_type":"4"}},{"id":1142146,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T22:31:42.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":30815,"source":{"system":"sec-edgar","filing":"0000950170-25-074662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017025074662/ownership.xml","form_type":"4"}},{"id":1444648,"issuer":{"id":2904,"kind":"organization","name":"MCKESSON CORP","symbol":"MCK"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-08-01T21:40:23.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board."}],"balance_after":349,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":349},"source":{"system":"sec-edgar","filing":"0001062993-24-014315","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927653/000106299324014315/form4.xml","form_type":"4"}},{"id":1472906,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T18:29:35.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":9900,"derivative":{"exercise_price":37.42,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0000950170-24-075491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017024075491/ownership.xml","form_type":"4"}},{"id":1472905,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T18:29:35.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":5345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":25075,"source":{"system":"sec-edgar","filing":"0000950170-24-075491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017024075491/ownership.xml","form_type":"4"}},{"id":1486333,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-07T20:30:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-24-070704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017024070704/ownership.xml","form_type":"4"}},{"id":1486332,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:30:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":5.3,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-24-070704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017024070704/ownership.xml","form_type":"4"}},{"id":1493547,"issuer":{"id":2904,"kind":"organization","name":"MCKESSON CORP","symbol":"MCK"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-06-04T20:42:23.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":56,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted to reporting person upon election to the Board pursuant to a prorated automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however receipt of the underlying stock is deferred until the director leaves the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"RSUs granted to reporting person upon election to the Board pursuant to a prorated automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however receipt of the underlying stock is deferred until the director leaves the Board."}],"balance_after":56,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":56},"source":{"system":"sec-edgar","filing":"0001062993-24-011837","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927653/000106299324011837/form4.xml","form_type":"4"}},{"id":1491655,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-04T20:42:09.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vested in their entirety on the first anniversary of the date of grant of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vested in their entirety on the first anniversary of the date of grant of the award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-24-068759","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017024068759/ownership.xml","form_type":"4"}},{"id":1491654,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:42:09.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000950170-24-068759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000095017024068759/ownership.xml","form_type":"4"}},{"id":1860221,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:29:27.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":7110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024"}],"balance_after":7110,"derivative":{"exercise_price":51.82,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":7110},"source":{"system":"sec-edgar","filing":"0001209191-23-035687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919123035687/doc4.xml","form_type":"4"}},{"id":1860220,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T18:29:27.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":3860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":19730,"source":{"system":"sec-edgar","filing":"0001209191-23-035687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919123035687/doc4.xml","form_type":"4"}},{"id":1869238,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-02T20:23:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-033718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919123033718/doc4.xml","form_type":"4"}},{"id":1869237,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:23:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":3.7,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-033718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919123033718/doc4.xml","form_type":"4"}},{"id":2155362,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-19T21:08:47.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022."}],"balance_after":12000,"derivative":{"exercise_price":7.349,"expiration_date":"2032-09-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-050550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919122050550/doc4.xml","form_type":"4"}},{"id":2155361,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T21:08:47.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-22-050550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919122050550/doc4.xml","form_type":"4"}},{"id":2220025,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T17:48:01.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":6245,"derivative":{"exercise_price":60.57,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":6245},"source":{"system":"sec-edgar","filing":"0001209191-22-039561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919122039561/doc4.xml","form_type":"4"}},{"id":2220024,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T17:48:01.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":15870,"source":{"system":"sec-edgar","filing":"0001209191-22-039561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919122039561/doc4.xml","form_type":"4"}},{"id":2247121,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T23:10:54.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":0.78,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-033716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919122033716/doc4.xml","form_type":"4"}},{"id":2573006,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-10T21:30:01.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":35000,"derivative":{"exercise_price":5.28,"expiration_date":"2031-09-08","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-055509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919121055509/doc4.xml","form_type":"4"}},{"id":2626563,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-23T16:48:29.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":14629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC. In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the \"Merger Consideration\").  Upon the First Effective Time, 2,495  restricted stock units were fully vested and cancelled and converted into the right to receive the Merger Consideration with respect to each share of Alexion common stock subject to such restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899866-21-000073","document":"wf-form4_162707329280008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000073/wf-form4_162707329280008.xml","form_type":"4"}},{"id":2653155,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T22:25:48.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":4125,"derivative":{"exercise_price":93.2,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-043545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919121043545/doc4.xml","form_type":"4"}},{"id":2653154,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-06-28T22:25:48.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":2145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":12570,"source":{"system":"sec-edgar","filing":"0001209191-21-043545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919121043545/doc4.xml","form_type":"4"}},{"id":2699672,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-05-24T16:27:27.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu ofthe annual cash retainer that the director was entitled to receive for service as a director."}],"balance_after":14629,"source":{"system":"sec-edgar","filing":"0000899866-21-000041","document":"wf-form4_162188802343001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000041/wf-form4_162188802343001.xml","form_type":"4"}},{"id":2699671,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-05-24T16:27:27.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the first anniversary of the grant date."}],"balance_after":14096,"source":{"system":"sec-edgar","filing":"0000899866-21-000041","document":"wf-form4_162188802343001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000041/wf-form4_162188802343001.xml","form_type":"4"}},{"id":3096409,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T17:10:55.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021."}],"balance_after":4250,"derivative":{"exercise_price":76.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-20-039404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919120039404/doc4.xml","form_type":"4"}},{"id":3096408,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T17:10:55.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021"}],"balance_after":10425,"source":{"system":"sec-edgar","filing":"0001209191-20-039404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919120039404/doc4.xml","form_type":"4"}},{"id":3146172,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-05-18T17:10:41.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director."}],"balance_after":12134,"source":{"system":"sec-edgar","filing":"0000899866-20-000043","document":"wf-form4_158983622375597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000043/wf-form4_158983622375597.xml","form_type":"4"}},{"id":3146171,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-05-18T17:10:41.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":3468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the earlier of (i) the first anniversary of the grant date and (ii) the date of the 2021 Annual Shareholder Meeting."}],"balance_after":11193,"source":{"system":"sec-edgar","filing":"0000899866-20-000043","document":"wf-form4_158983622375597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000043/wf-form4_158983622375597.xml","form_type":"4"}},{"id":3491061,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T20:38:18.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":58.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-036803","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919119036803/doc4.xml","form_type":"4"}},{"id":3491060,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T20:38:18.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001209191-19-036803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919119036803/doc4.xml","form_type":"4"}},{"id":3522263,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-05-17T16:34:57.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director."}],"balance_after":7725,"source":{"system":"sec-edgar","filing":"0000899866-19-000070","document":"wf-form4_155812528169706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000070/wf-form4_155812528169706.xml","form_type":"4"}},{"id":3522262,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-05-17T16:34:57.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the first anniversary of the grant date."}],"balance_after":6985,"source":{"system":"sec-edgar","filing":"0000899866-19-000070","document":"wf-form4_155812528169706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000070/wf-form4_155812528169706.xml","form_type":"4"}},{"id":3886963,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-20T22:16:28.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 19, 2019."}],"balance_after":5000,"derivative":{"exercise_price":80.69,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919118038861/doc4.xml","form_type":"4"}},{"id":3886962,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T22:16:28.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 19, 2019."}],"balance_after":4875,"source":{"system":"sec-edgar","filing":"0001209191-18-038861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919118038861/doc4.xml","form_type":"4"}},{"id":3937739,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-05-11T16:13:51.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Award vests on the anniversary of the grant date."}],"balance_after":4259,"source":{"system":"sec-edgar","filing":"0000899866-18-000093","document":"wf-form4_152606957030772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000093/wf-form4_152606957030772.xml","form_type":"4"}},{"id":4071037,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:15:30.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":2085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Award vests on the first anniversary of the grant date."}],"balance_after":2085,"source":{"system":"sec-edgar","filing":"0000899866-18-000034","document":"wf-form4_151813531591384.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000034/wf-form4_151813531591384.xml","form_type":"4"}},{"id":4274341,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-22T23:20:32.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 22, 2018."}],"balance_after":3750,"derivative":{"exercise_price":65.66,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-17-041468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919117041468/doc4.xml","form_type":"4"}},{"id":4274340,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T23:20:32.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 22, 2018."}],"balance_after":1875,"source":{"system":"sec-edgar","filing":"0001209191-17-041468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919117041468/doc4.xml","form_type":"4"}},{"id":4355365,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":29044,"kind":"person","name":"Dunsire Deborah","position":1,"cik":"0001332764","reported_name":"Dunsire Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-10T20:18:47.000Z","date":"2017-04-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest with respect to 1/36th of the shares monthly such that the options shall be fully vested on the third anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":58.59,"expiration_date":"2027-04-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-026421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1332764/000120919117026421/doc4.xml","form_type":"4"}}]}